Eurofins Scientific Se Stock Net Income
| ERFSF Stock | USD 79.88 0.57 0.72% |
As of the 18th of February 2026, Eurofins Scientific shows the Coefficient Of Variation of 1315.14, downside deviation of 2.76, and Mean Deviation of 2.4. Eurofins Scientific technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Eurofins Scientific treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Eurofins Scientific is priced favorably, providing market reflects its regular price of 79.88 per share. Given that Eurofins Scientific has jensen alpha of 0.2051, we urge you to verify Eurofins Scientific SE's prevailing market performance to make sure the company can sustain itself at a future point.
Eurofins Scientific's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Eurofins Scientific's valuation are provided below:Eurofins Scientific SE does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Eurofins |
Eurofins Scientific 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eurofins Scientific's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eurofins Scientific.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Eurofins Scientific on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Eurofins Scientific SE or generate 0.0% return on investment in Eurofins Scientific over 90 days. Eurofins Scientific is related to or competes with BioMrieux, CochLear, Cochlear, Swedish Orphan, Olympus, and CSPC Pharmaceutical. Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worl... More
Eurofins Scientific Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eurofins Scientific's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eurofins Scientific SE upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.76 | |||
| Information Ratio | 0.0587 | |||
| Maximum Drawdown | 13.7 | |||
| Value At Risk | (4.41) | |||
| Potential Upside | 5.8 |
Eurofins Scientific Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eurofins Scientific's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eurofins Scientific's standard deviation. In reality, there are many statistical measures that can use Eurofins Scientific historical prices to predict the future Eurofins Scientific's volatility.| Risk Adjusted Performance | 0.0678 | |||
| Jensen Alpha | 0.2051 | |||
| Total Risk Alpha | 0.0569 | |||
| Sortino Ratio | 0.0648 | |||
| Treynor Ratio | 0.5608 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eurofins Scientific's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Eurofins Scientific February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0678 | |||
| Market Risk Adjusted Performance | 0.5708 | |||
| Mean Deviation | 2.4 | |||
| Semi Deviation | 2.52 | |||
| Downside Deviation | 2.76 | |||
| Coefficient Of Variation | 1315.14 | |||
| Standard Deviation | 3.05 | |||
| Variance | 9.32 | |||
| Information Ratio | 0.0587 | |||
| Jensen Alpha | 0.2051 | |||
| Total Risk Alpha | 0.0569 | |||
| Sortino Ratio | 0.0648 | |||
| Treynor Ratio | 0.5608 | |||
| Maximum Drawdown | 13.7 | |||
| Value At Risk | (4.41) | |||
| Potential Upside | 5.8 | |||
| Downside Variance | 7.64 | |||
| Semi Variance | 6.34 | |||
| Expected Short fall | (2.70) | |||
| Skewness | 0.3534 | |||
| Kurtosis | 0.054 |
Eurofins Scientific Backtested Returns
Eurofins Scientific appears to be very steady, given 3 months investment horizon. Eurofins Scientific secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Eurofins Scientific SE, which you can use to evaluate the volatility of the firm. Please utilize Eurofins Scientific's Mean Deviation of 2.4, downside deviation of 2.76, and Coefficient Of Variation of 1315.14 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Eurofins Scientific holds a performance score of 9. The firm shows a Beta (market volatility) of 0.4, which means possible diversification benefits within a given portfolio. As returns on the market increase, Eurofins Scientific's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eurofins Scientific is expected to be smaller as well. Please check Eurofins Scientific's treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to make a quick decision on whether Eurofins Scientific's price patterns will revert.
Auto-correlation | -0.51 |
Good reverse predictability
Eurofins Scientific SE has good reverse predictability. Overlapping area represents the amount of predictability between Eurofins Scientific time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eurofins Scientific price movement. The serial correlation of -0.51 indicates that about 51.0% of current Eurofins Scientific price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.51 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 6.27 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Eurofins Scientific SE reported net income of 782.6 M. This is 129.31% higher than that of the Healthcare sector and significantly higher than that of the Diagnostics & Research industry. The net income for all United States stocks is 37.06% lower than that of the firm.
Eurofins Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eurofins Scientific's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Eurofins Scientific could also be used in its relative valuation, which is a method of valuing Eurofins Scientific by comparing valuation metrics of similar companies.Eurofins Scientific is currently under evaluation in net income category among its peers.
Eurofins Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.075 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 15.96 B | |||
| Shares Outstanding | 192.56 M | |||
| Shares Owned By Insiders | 32.76 % | |||
| Shares Owned By Institutions | 36.56 % | |||
| Price To Earning | 21.61 X | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 1.95 X | |||
| Revenue | 6.72 B | |||
| Gross Profit | 1.91 B | |||
| EBITDA | 1.7 B | |||
| Net Income | 782.6 M | |||
| Cash And Equivalents | 718.8 M | |||
| Cash Per Share | 3.74 X | |||
| Total Debt | 2.08 B | |||
| Debt To Equity | 0.70 % | |||
| Current Ratio | 1.33 X | |||
| Book Value Per Share | 24.42 X | |||
| Cash Flow From Operations | 1.51 B | |||
| Earnings Per Share | 3.63 X | |||
| Price To Earnings To Growth | 29.46 X | |||
| Number Of Employees | 61 K | |||
| Beta | 0.63 | |||
| Market Capitalization | 13.82 B | |||
| Total Asset | 9.33 B | |||
| Retained Earnings | 187 M | |||
| Working Capital | 669 M | |||
| Current Asset | 1.49 B | |||
| Current Liabilities | 818 M | |||
| Z Score | 3.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 9.33 B | |||
| Last Dividend Paid | 1.0 |
About Eurofins Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eurofins Scientific SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eurofins Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eurofins Scientific SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Eurofins Pink Sheet
Eurofins Scientific financial ratios help investors to determine whether Eurofins Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eurofins with respect to the benefits of owning Eurofins Scientific security.